Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Amisulpride, sold under the brand names Socian and Barhemsys, is a medication used in the treatment of schizophrenia, acute psychotic episodes, depression, and nausea and vomiting. It is specifically used at lower doses intravenously to prevent and treat postoperative nausea and vomiting, at low doses by mouth to treat depression, and at higher doses by…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Amisulpride. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
nausea vomiting dopamine d2 treatment receptor schizophrenia use states depression subjects used united treat antipsychotics dysthymia 5-ht7 postoperative drug antidepressant
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Amisulpride | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Amisulpride | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Amisulpride | ATC code | N05AL05 (WHO) | 1.00 | infobox |
| Amisulpride | Bioavailability | 48% | 1.00 | infobox |
| Amisulpride | CAS Number | 71675-85-9 Y | 1.00 | infobox |
| Amisulpride | ChEBI | CHEBI:64045 Y | 1.00 | infobox |
| Amisulpride | ChEMBL | ChEMBL243712 Y | 1.00 | infobox |
| Amisulpride | ChemSpider | 2074 Y | 1.00 | infobox |
| Amisulpride | CompTox Dashboard (EPA) | DTXSID5042613 | 1.00 | infobox |
| Amisulpride | Drug class | Dopamine D2 and D3 receptor antagonist; Serotonin 5-HT2B and 5-HT7 receptor antagonist; Antipsychotic; Antidepressant; Antiemetic | 1.00 | infobox |
| Amisulpride | DrugBank | DB06288 Y | 1.00 | infobox |
| Amisulpride | ECHA InfoCard | 100.068.916 | 1.00 | infobox |
| Amisulpride | Elimination half-life | 12 hours | 1.00 | infobox |
| Amisulpride | Excretion | Kidney (23–46%), Faecal | 1.00 | infobox |
| Amisulpride | Formula | C17H27N3O4S | 1.00 | infobox |
| Amisulpride | IUPHAR/BPS | 963 | 1.00 | infobox |
| Amisulpride | KEGG | D07310 Y | 1.00 | infobox |
| Amisulpride | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Amisulpride | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Amisulpride | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Amisulpride | Legal status | US: ℞-only | 1.00 | infobox |
| Amisulpride | License data | US DailyMed: Amisulpride | 1.00 | infobox |
| Amisulpride | License data | US FDA: Barhemsys | 1.00 | infobox |
| Amisulpride | Metabolism | Liver (minimal; most excreted unchanged) | 1.00 | infobox |
| Amisulpride | Molar mass | 369.48 g·mol−1 | 1.00 | infobox |
| Amisulpride | Other names | Aminosultopride; AST; APD-421; APD421; APD-403; APD403; DAN-2163; DAN2163 | 1.00 | infobox |
| Amisulpride | Pregnancy category | AU: C | 1.00 | infobox |
| Amisulpride | Protein binding | 16% | 1.00 | infobox |
| Amisulpride | PubChem CID | 2159 | 1.00 | infobox |
| Amisulpride | Routes of administration | By mouth, intravenous | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.